Enhanced perigraft angiogenesis prevents prosthetic graft infection.
暂无分享,去创建一个
Y. Tabata | M. Kaku | Y. Saiki | K. Tabayashi | Shin'ichi Sato | A. Iguchi | S. Kawamoto | Y. Nitta
[1] J. Coselli,et al. Options for managing infected ascending aortic grafts. , 2007, The Journal of thoracic and cardiovascular surgery.
[2] Y. Tabata,et al. A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice , 2007, Heart and Vessels.
[3] Y. Saiki,et al. Redo total aortic arch replacement using an extended homograft for graft infection. , 2006, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[4] Ying Liu,et al. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] Y. Tabata,et al. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. , 2005, British journal of plastic surgery.
[6] D. Hicklin,et al. Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Y. Saiki,et al. Vacuum-assisted closure system for the treatment of mediastinitis after total aortic arch replacement. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[8] R. Koerfer,et al. Clinical outcome of patients with deep sternal wound infection managed by vacuum-assisted closure compared to conventional therapy with open packing: a retrospective analysis. , 2005, The Annals of thoracic surgery.
[9] Y. Tabata,et al. Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. , 2004, The Journal of thoracic and cardiovascular surgery.
[10] Brian H Annex,et al. Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial , 2003 .
[11] Masashi Komeda,et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model , 2003, Heart and Vessels.
[12] J. Shrager,et al. Omentum is highly effective in the management of complex cardiothoracic surgical problems. , 2003, The Journal of thoracic and cardiovascular surgery.
[13] W. Kamysz,et al. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. , 2002, Journal of vascular surgery.
[14] R. Lederman,et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.
[15] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[16] Y. Tabata,et al. Novel Method to Enhance Sternal Healing After Harvesting Bilateral Internal Thoracic Arteries With Use of Basic Fibroblast Growth Factor , 2000, Circulation.
[17] A. Quyyumi,et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. , 2000, Journal of the American College of Cardiology.
[18] J. Coselli,et al. Management of thoracic aortic graft infections. , 1999, The Annals of thoracic surgery.
[19] K Walsh,et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.
[20] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[21] Y. Ikada,et al. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels , 1994 .
[22] D. Rifkin,et al. Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.
[23] Ana D. Lopez,et al. An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. , 1987, Biochemical and biophysical research communications.
[24] Y. Tabata,et al. Less-invasive and highly effective method for preventing methicillin-resistant Staphylococcus aureus graft infection by local sustained release of vancomycin. , 2008, The Journal of thoracic and cardiovascular surgery.
[25] Y. Saiki,et al. Vacuum-assisted Closure System for the of Mediastinitis after Total Aortic Arch Replacement Treatment , 2005 .
[26] M. Back,et al. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. , 2001, The Journal of surgical research.
[27] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.